Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL929611 | 0.75 | IDO1 (0.44) | HTR2CGAAMEN1MAPK1KMT2A | |
| SCHEMBL2594989 | 0.73 | MAPT (0.43) | GAACA1CA2CA7CA9 | |
| SCHEMBL14345499 | 0.73 | HTR2C (0.33) | HTR2CCYP2D6 | |
| SCHEMBL2594926 | 0.72 | MAPT (0.38) | GAACA1CA2CA7CA9 | |
| SCHEMBL8931460 | 0.69 | APLNR (0.33) | HTR2CADRA2A | |
| SCHEMBL19564699 | 0.68 | HTR2A (0.41) | HTR2CGAACA1CA2CA7 | |
| SCHEMBL6203758 | 0.66 | CA1 (0.52) | CYP2D6CA1CA2CA7CA9 | |
| SCHEMBL22909980 | 0.58 | CES2 (0.47) | CYP2D6GAACA9 | |
| SCHEMBL2588953 | 0.57 | ADRA2A (0.45) | HTR2CCYP2D6ADRA2AADRA1AMEN1 | |
| SCHEMBL12075669 | 0.57 | IDO1 (0.50) | CA1CA2CA7CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3246027-A1 | INDOLE DERIVATIVES FOR THE TREATMENT OF CANCER | GlaxoSmithKline LLC (US) | 2017-11-22 | — | — | EP | disclosed |